Category: PharmaceuticalsSyndicate content

Error: You have no payments from pharma

July 22, 2014 by MassDevice

Doctors checking a soon-to-be-unveiled federal website that will publicly list drug company payments are encountering error messages if they have not accepted industry money.

Error: You have no payments from pharma
(David Sleight/ProPublica)

by Charles Ornstein, ProPublica

The federal government has a word for physicians who don't have financial relationships with pharmaceutical and medical device manufacturers: "Error."

Allergan cuts 1,500 jobs, faces SEC complaint

July 21, 2014 by Arezu Sarvestani

Botox-maker Allergan announces restructuring measures that will cut 13% of its global workforce as the company sinks deeper into a months-long battle against activist investors and attempts at a takeover.

Updated July 21, 2014, at 12:40 p.m. EST with additional information on Allergan's earnings.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

A countdown to failure for Valeant's hostile $53B Allergan takeover

July 18, 2014 by Arezu Sarvestani

Activist investor Bill Ackman urges shareholders to take action before time runs out on Valeant Pharmaceuticals' hostile $53 billion bid to acquire Allergan.

A countdown to failure for Valeant's hostile $53B Allergan takeover

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abbott to deal pharma line to Mylan for $5.3B

July 14, 2014 by Brad Perriello

Abbott agrees to deal its specialty and branded generic pharmaceutical line to Mylan for $5.3 billion.

Abbott to deal pharma line to Mylan for $5.3B

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Stryker to deal bone growth protein assets to Mariel Therapeutics

July 9, 2014 by Brad Perriello

Stryker Corp. agrees to sell its bone morphogenetic protein-7 assets to Mariel Therapeutics, which plans to investigate BMP-7 as a possible treatment for a variety of conditions.

Stryker to deal bone growth protein assets to Mariel Therapeutics

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Another activist investor pressures Allergan to sell

June 27, 2014 by Arezu Sarvestani

Another hedge fund buys a massive stake in Botox-maker Allergan, throwing its support behind Valeant Pharmaceuticals' unrequited acquisition bid, according to a report.

Report: Another activist investor pressures Allergan to sell

Another player entered the arena in the running saga over Allergan (NYSE:AGN) as hedge fund Paulson & Co bought up a huge chunk of the Botox-maker's shares, according to Reuters.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Valeant goes hostile in bid for Allergan

June 18, 2014 by Arezu Sarvestani

Valeant Pharmaceuticals makes its promised hostile play in a $53 billion attempt to take over Botox-maker Allergan.

Valeant goes hostile in bid for Allergan

Valeant Pharmaceuticals is preparing to officially launch its long-promised hostile takeover bid for Allergan (NYSE:AGN), aiming to solicit support from Allergan shareholders to host a special meeting outside of the company's control.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp